Spice drugs: cannabinoids as a new designer drugs

被引:37
|
作者
Mustata, Cristina [1 ,2 ]
Torrens, Marta [1 ,3 ]
Pardo, Ricardo [1 ,2 ]
Perez, Clara [1 ,2 ]
Farre, Magi [1 ,2 ]
机构
[1] Hosp del Mar, IMIM, Unidad Farmacol Humana & Neurociencias, Programa Neuropsicofarmacol, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] Hosp del Mar, IMIM, Unidad Toxicomanias, Inst Atencio Psiquiatr Salut Mental & Toxicomanie, Barcelona 08003, Spain
关键词
Spice drugs; synthetic cannabinoids designer drugs; JWH-018; CP; 47497; JWH-073; HU-210; RECEPTORS; CB1; CLASSIFICATION; PHARMACOLOGY; ANANDAMIDE; AGONISTS;
D O I
10.20882/adicciones.227
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Some smokable herbal mixtures under the brand name Spice drugs have been sold on the Internet and in specialised shops (smart shops) since 2004. The mixtures are advertised as an exotic incense blend which releases a rich aroma and not for human consumption. When smoked, Spice drugs products have been reported by some users to have effects similar to those of cannabis. Spice drugs have received intensive attention in drug forums due to the possibility to obtain a non legal substitute of cannabis. Forensic analyses have found different potent synthetic cannabinoid agonists in some Spice drugs products, as JWH-018, CP 47497, JWH-073 and HU-210. There are few data about its pharmacological properties in animals, but nothing about its toxicity. At present, almost nothing is known about the pharmacology, toxicology and safety profile of such compounds in humans, except the opinions of consumers in internet forums. Neither the herbal ingredients of Spice drugs, nor any of the synthetic cannabinoids found in them, are internationally controlled under the 1961 or 1971 UN drug control conventions. Some European countries have recently taken legal actions to ban or otherwise control Spice drugs products and related compounds. These cannabinoid substances can be considered as new products to be added to the list of "designer drugs".
引用
收藏
页码:181 / 186
页数:6
相关论文
共 50 条
  • [1] Synthetic Cannabinoids: A New Frontier of Designer Drugs
    Gunderson, Erik W.
    ANNALS OF INTERNAL MEDICINE, 2013, 159 (08) : 563 - +
  • [2] Synthetic cannabinoids: the hidden side of Spice drugs
    Pintori, Nicholas
    Loi, Barbara
    Mereu, Maddalena
    BEHAVIOURAL PHARMACOLOGY, 2017, 28 (06): : 409 - 419
  • [3] New Designer Drugs (Synthetic Cannabinoids and Synthetic Cathinones): Review of Literature
    Cottencin, Olivier
    Rolland, Benjamin
    Karila, Laurent
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (25) : 4106 - 4111
  • [4] Isomeric Analysis of Synthetic Cannabinoids Detected as Designer Drugs
    Uchiyama, Nahoko
    Kikura-Hanajiri, Ruri
    Shoda, Takuji
    Fukuhara, Kiyoshi
    Goda, Yukihiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (07): : 1141 - 1147
  • [5] Synthetic Cannabinoids as Designer Drugs: A Structural Overview.
    Mahadevan, A.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S20 - S20
  • [6] New Designer Drugs
    Levine, Michael
    Lovecchio, Frank
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2021, 39 (03) : 677 - 687
  • [7] Detection and Quantification of New Designer Drugs in Human Blood: Part 1 Synthetic Cannabinoids
    Ammann, Julia
    McLaren, Jenna M.
    Gerostamoulos, Dimitri
    Beyer, Jochen
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2012, 36 (06) : 372 - 380
  • [8] Chemical analysis of synthetic cannabinoids as designer drugs in herbal products
    Uchiyama, Nahoko
    Kikura-Hanajiri, Ruri
    Ogata, Jun
    Goda, Yukihiro
    FORENSIC SCIENCE INTERNATIONAL, 2010, 198 (1-3) : 31 - 38
  • [9] The new word in designer drugs
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7149): : 1930 - 1930
  • [10] Bioanalysis of new designer drugs
    Wohlfarth, Ariane
    Weinman, Wolfgang
    BIOANALYSIS, 2010, 2 (05) : 965 - 979